Close Menu

More articles about Immunoassays

The kit, developed by Gauss in collaboration with Cellex, uses a smartphone app to instruct an individual on how to collect a sample and perform the test.

Ginolis provides robotics systems for manufacturing of multiplex tests, lateral flow, point-of-care tests, and medical devices.

The company said that the test, which detects IgG antibodies against SARS-CoV-2, can be used to measure immune responses to the virus and vaccines.

VolitionRx, which develops epigenetic-based blood tests for cancer and other diseases, said it will use the proceeds of the offering for general corporate purposes.

Atrys Health will offer and distribute Kantaro's SARS-CoV-2 IgG antibody test kits in parts of Europe and South America.

The company said the money, which includes seed funding from Novalis Biotech, will be used in part to support the development of a saliva-based SARS-CoV-2 antigen test.

The firms said that Abcam will be the preferred supplier of gold nanoparticles and custom conjugation reagents and services for Abingdon's lateral flow assays.

Under the exclusive agreement, Thermo Fisher is distributing Mindray's BS-480 and BA-800M clinical chemistry analyzers together with its own assays in the US and Canada.

During laboratory validation, the test showed sensitivity against high viral loads of 97.1 percent and specificity of 99.9 percent, the UK government said.

Mologic will help Avacta secure CE marking for one of its SARS-CoV-2 tests, as well as assist it with test manufacturing and distribution.

Roche has invested CHF 600 million ($664 million) in manufacturing to add 90 manufacturing lines and has plans to launch 17 new tests in 2021.

BD is reinvesting some of its $668 million Veritor Dx windfall into expanding the menu for a newly tripled installed base.

The firm attributed the revenue growth in part to $867 million in sales of molecular and antigen diagnostics for COVID-19.

The firm said that hospitals and private laboratories in key European markets will now be able to run the tests on the firm's Vidas 3 fully benchtop system.

The test was the first OTC at-home test for the coronavirus to receive EUA from the FDA in December. The US will procure 8.5 million tests.

The test is less invasive than Roche's existing rapid antigen test for SARS-CoV-2, which collects its sample from the nasopharynx.

The acquisition will bring Technopath's chemistry and immunoassay controls into LGC's clinical diagnostics business unit.

The company's revenue growth continues to be driven by its Alba reagents business, with some contribution from its SARS-CoV-2 antibody microarray.

The company's life sciences revenues grew 76 percent, while diagnostics revenues increased 24 percent.

Ortho said it intends to use the net proceeds from the offering to redeem senior notes and repay borrowings under its dollar term loan facility, among other uses.